<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To examine the changes in glycemic excursions that occur during pregnancy using continuous <z:chebi fb="105" ids="17234">glucose</z:chebi> monitoring and to compare patterns of glycemia in pregnant women with type 1 and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: An observational data analysis was performed from a prospective randomized study of continuous <z:chebi fb="105" ids="17234">glucose</z:chebi> monitoring in 57 women with pregestational type 1 (n = 40) or type 2 (n = 17) <z:mp ids='MP_0002055'>diabetes</z:mp> with 7-day continuous <z:chebi fb="105" ids="17234">glucose</z:chebi> monitoring system profiles during each trimester </plain></SENT>
<SENT sid="2" pm="."><plain>Serial <z:chebi fb="105" ids="17234">glucose</z:chebi> measurements were divided into periods of euglycemia (70-140 mg/dl), <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> (&gt;140 mg/dl), and <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> (&lt;70 mg/dl) </plain></SENT>
<SENT sid="3" pm="."><plain>Generalized linear mixed effects models were fitted to the repeated measures data to determine how these glycemic characteristics varied during gestation and by <z:mp ids='MP_0002055'>diabetes</z:mp> type </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: A total of 180 continuous <z:chebi fb="105" ids="17234">glucose</z:chebi> profiles were examined (140 type 1 <z:mp ids='MP_0002055'>diabetes</z:mp>, 40 type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>), providing 20,433 h of data for analysis (16,117 h type 1 <z:mp ids='MP_0002055'>diabetes</z:mp>, 4,316 type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>) </plain></SENT>
<SENT sid="5" pm="."><plain>Women with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> spend approximately 33% less time hyperglycemic throughout pregnancy than women with type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> (P = 0.005), with a significantly more rapid reduction in time spent hyperglycemic in early pregnancy (P = 0.02) </plain></SENT>
<SENT sid="6" pm="."><plain>Although women with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> spend less overall time hypoglycemic (P = 0.04), their risk of nocturnal <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> is equivalent to that of women with type 1 <z:mp ids='MP_0002055'>diabetes</z:mp> (blood <z:chebi fb="105" ids="17234">glucose</z:chebi> level &lt;70 mg/dl, P = 0.9; blood <z:chebi fb="105" ids="17234">glucose</z:chebi> level &lt;50 mg/dl, P = 0.2) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Continuous <z:chebi fb="105" ids="17234">glucose</z:chebi> monitoring reveals clear differences in the level of glycemic control that exist in women with type 1 and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>These data will guide therapeutic interventions aimed at optimizing glycemic control and improving the pregnancy outcomes of both type 1 and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>